High-flow nasal oxygen therapy decrease the risk of mortality and the use of invasive mechanical ventilation in patients with severe SARS-CoV-2 pneumonia? A retrospective and comparative study of 265 cases.

ABSTRACT:

Introduction

Corona virus disease (Covid-19) affects the airways and induces pulmonary lesions, patients with this disease require oxygen therapy as the disease progresses. Several oxygenation options have been used, l'HFNO had showed beneficial effects.

The objective of this study

To evaluate the efficacy of high-flow nasal oxygen HFNO versus non-invasive ventilation in COVID-19.

Methods

This is a retrospective and comparative study conducted over a period of 10 months from March 2020 to December 2020 and involving 600 patients hospitalized in the intensive care unit of the CHU Mohammed VI of Oujda for the management of acute respiratory failure caused by COVID-19.

Results

Out of 600 patients with acute respiratory failure, 265 patients were included in the an

SUBMITTER: Alkouh R 

PROVIDER: S-EPMC8724016 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature